Revolution Medicines, Inc. (RVMD) NASDAQ

53.49

-0.52(-0.96%)

Updated at October 21 04:00PM

Currency In USD

Valuation

Market Cap7.34B
Enterprise Value6.93B
P/E Ratio-12.59
PEG Ratio1.58
Price/Sales Ratio0
Price/Book Ratio5.48
Enterprise/Revenue0
Enterprise/EBITDA-11.19

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.33
Return On Equity-0.42

Income Statement

Revenue0
Revenue/Share0
Gross Profit-592.23M
EBITDA-589.02M
Net Income-600.09M
Diluted EPS-3.58

Balance Sheet

Total Cash2.14B
Total Cash/Share11.36
Total Debt132.79M
Total Debt/Equity0.07
Current Ratio11.79
Book Value Per Share9.91

Price History

52-Week Change13.81
52-Week High62.4
52-Week Low29.17
Moving Average 50 Days42.72
Moving Average 200 Days40.01

Statistics

Average Volume2.2M
Shares Outstanding186.93M
% Held by Institutions98.42

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A